In:
Clinical Oncology and Research, Science Repository OU
Kurzfassung:
Cervical cancer has the highest mortality rate worldwide. In the quest for reducing such a high mortality
rate, advancements in diagnosis as well as treatment are being undertaken at various scales across the globe. With the recent advancements in the applications of nanotechnology, simple, rapid and inexpensive
diagnostic methods for cervical cancer, i.e., human papillomavirus (HPV), especially high-risk oncogenic subtypes 16 and 18 have started to gain attention of health care practitioners. This review outlines the current
applications of biosensors for the diagnosis of HPV, as compared to the conventional techniques for measuring HPV that have some limitations. The traditional methods used for cervix cancer are less sensitive,
whereas nanotechnology has greatly improved the sensitivity. Due to cancer incidence and mortality growing rapidly worldwide, the prevalence and risk factors are also discussed in this review.
Materialart:
Online-Ressource
ISSN:
2613-4942
,
2613-4942
DOI:
10.31487/j.COR.2021.06.02
Sprache:
Unbekannt
Verlag:
Science Repository OU
Publikationsdatum:
2021
Permalink